Development of high-specificity antibodies against renal urate transporters using genetic immunization

Journal of Biochemistry and Molecular Biology

Volumn 39, Issue 6, 2006, Pages 696-702

  Xu, Guoshuang ^a   Chen, Xiangmei ^a   Wu, Di ^a   Shi, Suozhu ^a   Wang, Jianzhong ^a   Ding, Rui ^a   Hong, Quan ^a   Feng, Zhe ^a   Lin, Shupeng ^a   Lu, Yang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Antibodies; Genetic immunization; Kidney; Mice; Transporters; Uric acid urate

Indexed keywords

EID: 33845421704     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2006.39.6.696     Document Type: Article

References (35)

1. Alderman, M. H. (2001) Serum uric acid as a cardiovascular risk factor for heart disease. Curr. Hypertens. Rep. 3, 184-189.
2. Babiuk, L. A., van Drunen, Littel-van den Hurk and Babiuk, S. L. (1999) Immunization of animals: from DNA to the dinner plate. Vet. Immunol. Immunopathol. 72, 189-202.
3. Baca-Estrada, M. E., Ewen, C., Mahony, D., Babiuk, L. A., Wilkie, D. and Foldvari, M. (2002) The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization. Immunology 107, 69-76.
4. Barouch, D. H., Letvin, N. L. and Seder, R. A. (2004) The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev. 202, 266-274.
5. Capasso, G., Jaeger, P., Robertson, W. G. and Unwin, R. J. (2005) Uric acid and the kidney: urate transport, stone disease and progressive renal failure. Curr. Pharm. Des. 11, 4153-4159.
6. Cha, S. H., Sekine, T., Fukushima, J. I., Kanai, Y., Kobayashi, Y., Goya, T. and Endou, H. (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol. 59, 1277-1286.
7. Chambers, R. S. and Johnston, S. A. (2003) High-level generation of polyclonal antibodies by genetic immunization. Nat. Biotechnol. 21, 1088-1092.
8. Cribbs, D. H., Ghochikyan, A., Vasilevko, V., Tran, M., Petrushina, I., Sadzikava, N., Babikyan, D., Kesslak, P., Kieber-Emmons, T., Cotman, C. W. and Agadjanyan, M. G. (2003) Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int. Immunol. 15, 505-514.
9. DiMartino, S. J., Shah, A. B., Trujillo, G. and Kew, R. R. (2001) Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity. J. Immunol. 166, 2688-2694.
10. Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Cha, S. H., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., Matsuo, H., Kikuchi, Y., Oda, T., Ichida, K., Hosoya, T., Shimokata, K., Niwa, T., Kanai, Y. and Endou, H. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447-452.
11. Feig, D, I. (2005) Uric acid and hypertension in adolescents. Semin. Nephrol. 25, 32-38.
12. Ghochikyan, A., Vasilevko, V., Petrushina, I, Movsesyan, N., Babikyan, D., Tian, W., Sadzikava, N., Ross, T. M., Head, E., Cribbs, D. H. and Agadjanyan, M. G. (2003) Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene. Eur. J. Immunol. 33, 3232-3241.
13. Hediger, M. A. (2002) Kidney function: gateway to a long life? Nature 417, 393-395.
14. Hediger, M. A., Johnson, R. J., Miyazaki, H. and Endou, H. (2005) Molecular physiology of urate transport. Physiology (Bethesda) 20, 125-133.
15. Hosoyamada, M., Ichida, K., Enomoto, A., Hosoya, T. and Endou, H. (2004) Function and localization of urate transporter 1 in mouse kidney. J. Am. Soc. Nephrol. 15, 261-268.
16. Hosoyamada, M., Sekine, T., Kanai, Y. and Endou, H. (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am. J. Physiol. 276, 122-128.
17. Hyink, D. P., Rappoport, J. Z., Wilson, P. D. and Abramson, R. G. (2001) Expression of the urate transporter/channel is developmentally regulated in human kidneys. Am. J. Physiol. Renal. Physiol. 281, 875-886.
18. Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K. and Takishita, S. (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am. J. Kidney Dis. 44, 642-650.
19. Kodadek, T. (2001) Protein microarrays; prospects and problems. Chem. Biol. 8, 105-115.
20. Kojima, R., Sekine, T., Kawachi, M., Cha, S. H., Suzuki, Y. and Endou, H. (2002) Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J. Am. Soc. Nephrol. 13, 848-857.
21. Lang, F., Greger, R. and Deetjen, P. (1972) Handling of uric acid by the rat kidney. II. Microperfusion studies on bidirectional transport of uric acid in the proximal tubule. Pflugers Arch. 335, 257-265.
22. Mount, D. B. (2005) Molecular physiology and the four-component model of renal urate transport. Curr. Opin. Nephrol. Hypertens. 14, 460-463.
23. Nakagawa, T., Mazzali, M., Kang, D. H., Kanellis, J., Watanabe, S., Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Herrera-Acosta, J. and Johnson, R. J. (2003) Hyperuricemia causes glomerular hypertrophy in the rat. Am. J. Nephrol. 23, 2-7.
24. Rafey, M. A., Lipkowitz, M. S., Leal-Pinto, E. and Abramson, R. G. (2003) Uric acid transport. Curr. Opin. Nephrol. Hypertens. 12, 511-516.
25. Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J. and Herrera-Acosta, J. (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 67, 237-247.
26. Schali, C. and Roch-Ramel, F. (1981) Uptake of [3H]PAH and [14C]urate into isolated proximal tubular segments of the pig kidney. Am. J. Physiol. 241, 591-596.
27. Sekine, H., Watanabe, H. and Gilkeson, G. S. (2004) Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J. Immunol. 172, 3913-3921.
28. Short, R. A. and Turtle, K. R. (2005) Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin. Nephrol. 25, 25-31.
29. Sun, W., Hu, Y., Gong, J., Zhu, C. and Zhu, B. (2005) Identification of beta-lactamase inhibitory peptide using yeast two-hybrid system. Biochemistry (Mosc) 70, 753-760.
30. Tang, D. C., DeVit, M. and Johnston, S. A. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
31. Trinchieri, G. (1998) Immunobiology of interleukin-12. Immunol. Res. 17, 269-278.
32. Verdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C. and Brunetti, P. (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36, 1072-1078.
33. Wang, Z., Yuan, Z., Matsumoto, M., Hengge, U. R. and Chang, Y. F. (2005) Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem. Biophys. Res. Commun. 327, 130-135.
34. Wu, J., Chen, X., Xie, Y., Yamanaka, N., Shi, S., Wu, D., Liu, S. and Cai, G (2005) Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol. Dial Transplant 20, 719-727.
35. Zheng, L. Y., Mou, L., Lin, S., Lu, R. M. and Luo, E. J. (2005) Enhancing DNA vaccine potency against hantavirus by co-administration of interleukin-12 expression vector as a genetic adjuvant. Chin. Med J. (Engl) 118, 313-319.